Merck Vioxx Formulary Status Retained Since VIGOR GI, CV Label Change
Executive Summary
Vioxx has retained key formulary positions and added new accounts since the VIGOR label change, Merck Human Health President-Europe Per Wold-Olsen said during the company's annual business briefing in Whitehouse Station, N.J., Dec. 10